Research ArticleExperimental Studies
Therapeutic Efficacy of PB101 and Chemotherapy Combination in Preclinical Gastric Cancer Models
MINSUNG PARK, CHENG HYUN LEE, KUI-JIN KIM, SUNG-HYUN HWANG, JI HEA SUNG, MILANG NAM, MINSU KANG, WOOCHAN PARK, JI-WON KIM, JIN WON KIM, SE HYUN KIM, JEONGMIN SEO, EUN HEE JUNG, KOUNG JIN SUH, YU JUNG KIM, JEE HYUN KIM, HYE SEONG LIM, HYUN GUL YANG, EUN BYUL CHO and KEUN-WOOK LEE
Anticancer Research May 2026, 46 (5) 2429-2443; DOI: https://doi.org/10.21873/anticanres.18128
MINSUNG PARK
1Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea;
CHENG HYUN LEE
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
KUI-JIN KIM
3Biomedical Research Institute, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
SUNG-HYUN HWANG
3Biomedical Research Institute, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
JI HEA SUNG
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
MILANG NAM
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
MINSU KANG
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
WOOCHAN PARK
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
JI-WON KIM
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
JIN WON KIM
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
SE HYUN KIM
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
JEONGMIN SEO
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
EUN HEE JUNG
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
KOUNG JIN SUH
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
YU JUNG KIM
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
JEE HYUN KIM
1Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea;
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
3Biomedical Research Institute, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
HYE SEONG LIM
4Panolos Bioscience, Inc., Hwaseong, Republic of Korea
HYUN GUL YANG
4Panolos Bioscience, Inc., Hwaseong, Republic of Korea
EUN BYUL CHO
4Panolos Bioscience, Inc., Hwaseong, Republic of Korea
KEUN-WOOK LEE
1Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea;
2Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;
3Biomedical Research Institute, Seoul National University Bundang Hospital, Seongnam, Republic of Korea;

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Anticancer Research
Vol. 46, Issue 5
May 2026
Therapeutic Efficacy of PB101 and Chemotherapy Combination in Preclinical Gastric Cancer Models
MINSUNG PARK, CHENG HYUN LEE, KUI-JIN KIM, SUNG-HYUN HWANG, JI HEA SUNG, MILANG NAM, MINSU KANG, WOOCHAN PARK, JI-WON KIM, JIN WON KIM, SE HYUN KIM, JEONGMIN SEO, EUN HEE JUNG, KOUNG JIN SUH, YU JUNG KIM, JEE HYUN KIM, HYE SEONG LIM, HYUN GUL YANG, EUN BYUL CHO, KEUN-WOOK LEE
Anticancer Research May 2026, 46 (5) 2429-2443; DOI: 10.21873/anticanres.18128
Therapeutic Efficacy of PB101 and Chemotherapy Combination in Preclinical Gastric Cancer Models
MINSUNG PARK, CHENG HYUN LEE, KUI-JIN KIM, SUNG-HYUN HWANG, JI HEA SUNG, MILANG NAM, MINSU KANG, WOOCHAN PARK, JI-WON KIM, JIN WON KIM, SE HYUN KIM, JEONGMIN SEO, EUN HEE JUNG, KOUNG JIN SUH, YU JUNG KIM, JEE HYUN KIM, HYE SEONG LIM, HYUN GUL YANG, EUN BYUL CHO, KEUN-WOOK LEE
Anticancer Research May 2026, 46 (5) 2429-2443; DOI: 10.21873/anticanres.18128
Jump to section
Related Articles
Cited By...
- No citing articles found.





